Medicine and Dentistry
Patient
100%
Analysis
76%
Insulin Dependent Diabetes Mellitus
66%
Diabetes
59%
Diabetes Mellitus
57%
Insulin Derivative
51%
Placebo
41%
Glomerular Filtration Rate
41%
Maturity Onset Diabetes of the Young
36%
Dulaglutide
36%
Serum Amyloid A
36%
Antisense Oligonucleotide
36%
Angiotensin II
36%
Oligonucleotide Targeting
36%
Abdominal Aortic Aneurysm
36%
Chronic Kidney Disease
36%
Empagliflozin
36%
Glucose
31%
Serums
27%
Cardiovascular System
26%
Age
25%
Infusion
25%
Heart Rate
25%
Creatinine
25%
Albumin
25%
Urinary System
25%
Kidney
24%
Man
22%
Arterial Pressure
21%
Nesidioblastosis
21%
Pressoreceptor Reflex
20%
Insulin Release
20%
Cell Antigen
20%
Blindness
20%
Neuropathy
20%
Human Insulin
20%
Recombinant Human Insulin
20%
Nephropathy
19%
High Fiber Diet
18%
NOD Mice
18%
Isotopes of Calcium
18%
Kidney Pancreas Transplantation
18%
Lymphocytic Lymphoma
18%
Autoantibodies
18%
Environmental Factor
18%
Liver Cell
18%
Carbohydrates
18%
Arginine
18%
Cells
18%
Adrenal Crisis
18%
Immunology and Microbiology
Immunology
80%
Antibodies
62%
Cells
56%
Cell Antigen
48%
Autoantibodies
41%
Age
38%
Diabetes Mellitus Type 1
38%
Antisense
36%
Serum Amyloid A
36%
Rat
35%
Antigen
34%
DNA Antibody
28%
ELISA
27%
Insulin Release
27%
C57BL 6 Mouse
27%
Recognition
26%
Human
24%
Auto-immunity
23%
Nonobese Diabetic Mouse
23%
Antibody Response
21%
Thymus
18%
Escherichia coli
18%
Glycemic Control
18%
Liver Cell
18%
Insulin Antibody
18%
Double Stranded DNA Antibody
18%
Cell Line
18%
Species
18%
Capsid
18%
Monoclonal Antibody
18%
Immunopathogenesis
18%
Systemic Lupus Erythematosus
18%
Normal Human
18%
DNA Vaccination
18%
T Cell
18%
Arterial Pressure
18%
Stress
18%
Heart Rate
18%
DNA Immunization
18%
Dose
16%
Epitope
13%
Time
13%
Western Blot
12%
Reduction (Chemistry)
11%
Staphylococcus
10%
Micrococcus luteus
10%
Titer
10%
Blood Pressure
10%
Micrococcus
9%
Testis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
54%
Placebo
41%
Serum Amyloid A
36%
Antisense Oligonucleotide
36%
Angiotensin II
36%
Oligonucleotide Targeting
36%
Abdominal Aortic Aneurysm
36%
Empagliflozin
36%
Chronic Kidney Failure
36%
N Ethyl 2 [N (6 Methoxy 3 Pyridinyl) 2 Methylbenzenesulfonamido] N (3 Pyridinylmethyl)acetamide
25%
Creatinine
25%
Albumin
25%
C57BL 6 Mouse
22%
Insulin
20%
Kidney Disease
19%
Insulin Dependent Diabetes Mellitus
18%
Insulin Glargine
18%
Nonobese Diabetic Mouse
18%
Adrenal Cortex Insufficiency
18%
Rosiglitazone
18%
Clinical Trial
18%
Human Insulin
18%
Dulaglutide
18%
Lipid
18%
Hydroxybutyric Acid
18%
Exendin 4
18%
Nitric Oxide
18%
Recombinant Human Insulin
18%
DNA
18%
Double Stranded DNA Antibody
18%
Bacterial DNA
18%
Antibodies
18%
Glucose
16%
Cardiovascular Disease
15%
Arginine
15%
Death
11%
Incidence
10%
Disease Exacerbation
9%
Diabetic Ketoacidosis
9%
DNA Immunization
9%
Enzyme-Linked Immunosorbent Assay
9%
Deterioration
8%
Macroalbuminuria
7%
Heart Infarction
7%
Cerebrovascular Accident
7%
Fat
7%
Infection
7%
Hemoglobin A1c
6%
Adrenal Insufficiency
6%
Inflammation
5%